Timing of Twin-Twin Transfusion Syndrome Diagnosis
Twin-Twin Transfusion Syndrome (TTTS) is most commonly diagnosed during the mid-trimester, typically between 16 and 26 weeks of gestation, though it can manifest at any point during pregnancy. 1
Typical Gestational Age at Diagnosis
TTTS typically arises between 15 and 26 weeks of gestation, representing the classic presentation window when the oligohydramnios-polyhydramnios sequence becomes evident. 2
Most cases are diagnosed in the mid-trimester, which aligns with the recommended surveillance protocol that begins at 16 weeks of gestation. 1
The presentation timing is highly variable, and while mid-trimester diagnosis is most common, TTTS can present at any gestational age during pregnancy. 1
Early vs. Late TTTS Presentations
Early TTTS (Before 18 weeks)
Early TTTS, defined as occurring before 18 weeks of gestation, accounts for approximately 14.3% of all TTTS cases. 3
The most severe cases typically become evident before 20 weeks of gestation. 4
TTTS occurring before 16 weeks represents an even earlier subset with particularly challenging management considerations. 3
Late TTTS (After 26 weeks)
Late TTTS, occurring at or after 26 weeks of gestation, represents approximately 8.7% of all TTTS cases. 5
Milder forms may not appear until 26-28 weeks of gestation. 4
Clinical Implications of Timing
The timing of TTTS presentation directly impacts prognosis and treatment options:
Advanced (Stage III) TTTS presenting before 26 weeks carries a particularly bleak prognosis, with reported perinatal loss rates of 70-100% without intervention. 6
Fetoscopic laser photocoagulation is the standard treatment for Stage II-IV TTTS diagnosed before 26 weeks of gestation. 1, 7
Cases presenting after 26 weeks require different management considerations, as the traditional laser therapy window has passed, though recent evidence suggests laser can still be performed up to 31 weeks with favorable outcomes. 8
Surveillance Strategy Based on Timing
All monochorionic diamniotic (MCDA) twin pregnancies require serial ultrasound surveillance beginning at 16 weeks of gestation and continuing every 2 weeks until delivery to ensure timely diagnosis regardless of when TTTS manifests. 1, 7, 4
This biweekly surveillance protocol has demonstrated effectiveness for timely TTTS diagnosis and low rates of Stage V TTTS (involving fetal demise). 1